Surgimatix is a pre-revenue stage medical device company that has developed a proprietary, soft tissue fixation platform technology to improve outcomes and reduce costs in minimally invasive surgical (MIS) procedures. The company has FDA 510(k) clearance for its first product, a patented medical device targeting the $1B US minimally invasive surgery market.